Pegilodecakin No Aid to FOLFOX in Metastatic Pancreatic Cancer
NEW YORK (Reuters Health) – Adding immunotherapy pegylated IL-10 (pegilodecakin) to folinic ac...
Immunomodulatory drugs improve the success rate of cancer therapies
Immunomodulatory drugs, including the Contergan de...
Aggressive brain tumor mapped in genetic, molecular detail
Glioblastoma is among the most aggressive and deva...
Anticancer drug may reduce mortality and speed up recovery for severe COVID-19 patients
Treating severe COVID-19 patients with the antican...
The Role of Cell Division in Tumor Formation
Humans are multicellular organisms, a complex syst...
Tumor cells reveal a core syncytial drive to evade host defenses
Toxins, radiation, and normal metabolic processes ...
Why we need detailed tumor profiling
Researchers from the University Hospitals in Zuric...
Molecular reporters expose the allies of the brain tumor
Glioblastoma is the most common malignant brain tu...
Researchers unlock the door to tumor microenvironment for CAR T cells
The labyrinth of jumbled blood vessels in the tumo...